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Online Supplement e-Figure 1. Geometric mean plasma concentration-time curves over 24 h following single doses of riociguat (0.5, 1, and 2 mg). Non-compartmental pharmacokinetic analyses were performed on plasma concentrations of riociguat. -5.5 to 11.6) .5
Galectin-3, ng/mL 8.5±1.8 b 0.1 9.2±4.0 0.1 6.8±2.3 -0.02 8.8±2.5 0.7 0.6 (-1.0 to 2.2)
.5 a Riociguat 2 mg vs placebo. b n = 10. The mean changes from baseline of the evaluations at 8 and 24 h after study drug administration are shown. ADMA = asymmetric dimethylarginine; NT-proBNP = N-terminal prohormone of brain natriuretic peptide.
Online supplements are not copyedited prior to posting. t max , h 2.5 b -0.5-8.0 2.0 b -0.6-2.9 1.9 b -0.7-8.0 a n = 8. b Median. The geometric means (standard deviation) are shown. AUC = area under the plasma concentration−time curve from zero to infinity; AUC/D = AUC/dose; AUC norm = area under the plasma concentration−time curve divided by dose per kg body weight; C max = peak plasma concentration; C max /D = C max /dose; CV = coefficient of variation; t max = time to reach maximum drug concentration in plasma; t 1/2 = half-life.
